ARCT

Arcturus Therapeutics Holdings (ARCT)

About Arcturus Therapeutics Holdings (ARCT)

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Details

Daily high

$17.93

Daily low

$15.92

Price at open

$16.40

52 Week High

$45.00

52 Week Low

$14.30

Market cap

453.4M

Dividend yield

0.00%

Volume

424,743

Avg. volume

369,479

P/E ratio

-7.56

Arcturus Therapeutics Holdings News